Functional Genomic Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the functional genomic market looks promising with opportunities in clinical and research laboratories, academic and government institutes, hospitals and clinics, and pharmaceutical & biotechnology companies. The global functional genomic market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are constantly reducing prices of genetic procedures and rising usage of genomics in R&D of new drugs.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global functional genomic market report, please download the report brochure.
In this market, PCR is the largest technology segment of functional genomic, whereas pharmaceutical & biotechnology companies is the fastest growing application. Growth in various segments of the functional genomic market are given below:
The study includes trends and forecast for the global functional genomic market by deliverable, technology, end user, and region as follows:
By Deliverable [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that PCR will remain the largest technology segment over the forecast period due to rising research activities and low cost of DNA (Deoxyribonucleic Acid) amplification using PCR.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to rising genetic research studies for development of drugs with fewer side effects and improving drug discovery process.
North America will remain the largest region over the forecast period due to rising investment in research by government organizations and presence of advanced healthcare infrastructure in the region.
Features of the Global Functional Genomic Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global functional genomic market by deliverable (products (instruments & softwares and consumables & reagents) and services (core genomics services, NGS-based services, biomarker translation services, computational services, and others)), technology (PCR, sequencing, microarray, nucleic acid extraction and purification, and other technologies), end user (clinical & research laboratories, academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global functional genomic market?
Q.5 What are the business risks and threats to the global functional genomic market?
Q.6 What are the emerging trends in this functional genomic market and the reasons behind them?
Q.7 What are some changing demands of customers in this functional genomic market?
Q.8 What are the new developments in this functional genomic market? Which companies are leading these developments?
Q.9 Who are the major players in this functional genomic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this functional genomic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global functional genomic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Deliverable (Products (Instruments & Softwares and Consumables & Reagents) and Services (Core Genomics Services, NGS-Based Services, Biomarker Translation Services, Computational Services, and Others)), Technology (PCR, Sequencing, Microarray, Nucleic Acid Extraction And Purification, and Other Technologies), and End User (Clinical & Research Laboratories, Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the functional genomic market looks promising with opportunities in clinical and research laboratories, academic and government institutes, hospitals and clinics, and pharmaceutical & biotechnology companies. The global functional genomic market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are constantly reducing prices of genetic procedures and rising usage of genomics in R&D of new drugs.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global functional genomic market report, please download the report brochure.
In this market, PCR is the largest technology segment of functional genomic, whereas pharmaceutical & biotechnology companies is the fastest growing application. Growth in various segments of the functional genomic market are given below:
The study includes trends and forecast for the global functional genomic market by deliverable, technology, end user, and region as follows:
By Deliverable [Value ($ Million) shipment analysis for 2014 – 2025]:
- Products
- Instruments and Softwares
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-based Services
- Biomarker Translation Services
- Computational Services
- Others
- Polymerase Chain Reaction (PCR)
- Sequencing
- Microarray
- Nucleic Acid Extraction and Purification
- Other Technologies
- Clinical and Research Laboratories
- Academic and Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Other End Users
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that PCR will remain the largest technology segment over the forecast period due to rising research activities and low cost of DNA (Deoxyribonucleic Acid) amplification using PCR.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to rising genetic research studies for development of drugs with fewer side effects and improving drug discovery process.
North America will remain the largest region over the forecast period due to rising investment in research by government organizations and presence of advanced healthcare infrastructure in the region.
Features of the Global Functional Genomic Market
- Market Size Estimates: Global functional genomic market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global functional genomic market size by various segments, such as deliverable, technology, and end user in terms of value.
- Regional Analysis: Global functional genomic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different deliverable, technology, end user, and region for the global functional genomic market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global functional genomic market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global functional genomic market by deliverable (products (instruments & softwares and consumables & reagents) and services (core genomics services, NGS-based services, biomarker translation services, computational services, and others)), technology (PCR, sequencing, microarray, nucleic acid extraction and purification, and other technologies), end user (clinical & research laboratories, academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global functional genomic market?
Q.5 What are the business risks and threats to the global functional genomic market?
Q.6 What are the emerging trends in this functional genomic market and the reasons behind them?
Q.7 What are some changing demands of customers in this functional genomic market?
Q.8 What are the new developments in this functional genomic market? Which companies are leading these developments?
Q.9 Who are the major players in this functional genomic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this functional genomic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global functional genomic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Deliverable (Products (Instruments & Softwares and Consumables & Reagents) and Services (Core Genomics Services, NGS-Based Services, Biomarker Translation Services, Computational Services, and Others)), Technology (PCR, Sequencing, Microarray, Nucleic Acid Extraction And Purification, and Other Technologies), and End User (Clinical & Research Laboratories, Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Functional Genomic Market Trends and Forecast
3.3: Global Genomics Market by Deliverable
3.3.1: Products
3.3.1.1: Instruments and Softwares
3.3.1.2: consumables and Reagents
3.3.2: Services
3.3.2.1: Core Genomics Services
3.3.2.2: NGS-based Services
3.3.2.3: Biomarker Translation Services
3.3.2.4: Computational Services
3.3.2.5: Others
3.4: Global Genomics Market by Technology
3.4.1: Polymerase Chain Reaction (PCR)
3.4.2: Sequencing
3.4.3: Microarray
3.4.4: Nucleic Acid Extraction and Purification
3.4.5: Other Technologies
3.5: Global Genomics Market by End User
3.5.1: Clinical and Research Laboratories
3.5.2: Academic and Government Institutes
3.5.3: Hospitals and Clinics
3.5.4: Pharmaceutical and Biotechnology Companies
3.5.5: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Functional Genomic Market by Region
4.2: North American Functional Genomic Market
4.2.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.2.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.2.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.2.4: The United States Functional Genomic Market
4.2.5: The Canadian Functional Genomic Market
4.2.6: The Mexican Functional Genomic Market
4.3: European Functional Genomic Market
4.3.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.3.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.3.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.3.4: The Functional Genomic Market of United Kingdom
4.3.5: The German Functional Genomic Market
4.3.6: The French Functional Genomic Market
4.4: APAC Functional Genomic Market
4.4.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.4.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.4.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.4.4: The Chinese Functional Genomic Market
4.4.5: The Indian Functional Genomic Market
4.4.6: The Japanese Functional Genomic Market
4.5: ROW Functional Genomic Market
4.5.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.5.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.5.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.5.4: Brazilian Functional Genomic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Functional Genomic Market by Deliverable
7.1.2: Growth Opportunities for the Global Functional Genomic Market by Technology
7.1.3: Growth Opportunities for the Global Functional Genomic Market by End User
7.1.4: Growth Opportunities for the Global Functional Genomic Market by Region
7.2: Emerging Trends in the Global Functional Genomic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Functional Genomic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Functional Genomic Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific, Inc.
8.2: Agilent Technologies, Inc.
8.3: Eppendorf AG
8.4: Bio-Rad Laboratories, Inc.
8.5: Company
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Functional Genomic Market Trends and Forecast
3.3: Global Genomics Market by Deliverable
3.3.1: Products
3.3.1.1: Instruments and Softwares
3.3.1.2: consumables and Reagents
3.3.2: Services
3.3.2.1: Core Genomics Services
3.3.2.2: NGS-based Services
3.3.2.3: Biomarker Translation Services
3.3.2.4: Computational Services
3.3.2.5: Others
3.4: Global Genomics Market by Technology
3.4.1: Polymerase Chain Reaction (PCR)
3.4.2: Sequencing
3.4.3: Microarray
3.4.4: Nucleic Acid Extraction and Purification
3.4.5: Other Technologies
3.5: Global Genomics Market by End User
3.5.1: Clinical and Research Laboratories
3.5.2: Academic and Government Institutes
3.5.3: Hospitals and Clinics
3.5.4: Pharmaceutical and Biotechnology Companies
3.5.5: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Functional Genomic Market by Region
4.2: North American Functional Genomic Market
4.2.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.2.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.2.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.2.4: The United States Functional Genomic Market
4.2.5: The Canadian Functional Genomic Market
4.2.6: The Mexican Functional Genomic Market
4.3: European Functional Genomic Market
4.3.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.3.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.3.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.3.4: The Functional Genomic Market of United Kingdom
4.3.5: The German Functional Genomic Market
4.3.6: The French Functional Genomic Market
4.4: APAC Functional Genomic Market
4.4.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.4.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.4.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.4.4: The Chinese Functional Genomic Market
4.4.5: The Indian Functional Genomic Market
4.4.6: The Japanese Functional Genomic Market
4.5: ROW Functional Genomic Market
4.5.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.5.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.5.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.5.4: Brazilian Functional Genomic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Functional Genomic Market by Deliverable
7.1.2: Growth Opportunities for the Global Functional Genomic Market by Technology
7.1.3: Growth Opportunities for the Global Functional Genomic Market by End User
7.1.4: Growth Opportunities for the Global Functional Genomic Market by Region
7.2: Emerging Trends in the Global Functional Genomic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Functional Genomic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Functional Genomic Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific, Inc.
8.2: Agilent Technologies, Inc.
8.3: Eppendorf AG
8.4: Bio-Rad Laboratories, Inc.
8.5: Company
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
